This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haristoy, X.
Right arrow Articles by Lozniewski, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haristoy, X.
Right arrow Articles by Lozniewski, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2003, p. 3982-3984, Vol. 47, No. 12
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.12.3982-3984.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Efficacy of Sulforaphane in Eradicating Helicobacter pylori in Human Gastric Xenografts Implanted in Nude Mice

Xavier Haristoy,1 Karine Angioi-Duprez,2 Adrien Duprez,3 and Alain Lozniewski1*

Laboratoire de Bactériologie-Virologie, UMR CNRS 75-65,1 Laboratoire de Microchirurgie Expérimentale,2 Laboratoire d'Anatomie Pathologique EMI INSERM 0014,Faculté de Médecine, Université Henri-Poincaré, Vandæuvre-les-Nancy, France3

Received 15 November 2002/ Returned for modification 24 May 2003/ Accepted 25 August 2003

Sulforaphane, an isothiocyanate abundant in the form of its glucosinolate precursor in broccoli sprouts, has shown in vitro activity against Helicobacter pylori. We evaluated the effect of sulforaphane in vivo against this bacterium by using human gastric xenografts in nude mice. H. pylori was completely eradicated in 8 of the 11 sulforaphane-treated grafts. This result suggests that sulforaphane might be beneficial in the treatment of H. pylori-infected individuals.


* Corresponding author. Mailing address: Laboratoire de Bactériologie, Hôpital Central, 29 Avenue du Maréchal de Lattre de Tassigny, 54035 Nancy Cedex, France. Phone: (33) 3 83 85 21 96. Fax: (33) 3 83 85 26 73. E-mail: a.lozniewski{at}chu-nancy.fr.


Antimicrobial Agents and Chemotherapy, December 2003, p. 3982-3984, Vol. 47, No. 12
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.12.3982-3984.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Yanaka, A., Fahey, J. W., Fukumoto, A., Nakayama, M., Inoue, S., Zhang, S., Tauchi, M., Suzuki, H., Hyodo, I., Yamamoto, M. (2009). Dietary Sulforaphane-Rich Broccoli Sprouts Reduce Colonization and Attenuate Gastritis in Helicobacter pylori-Infected Mice and Humans. Cancer Prevention Research 2: 353-360 [Abstract] [Full Text]  
  • Ragasa, R., Nakamura, E., Marrone, L., Yanaka, S., Hayashi, S., Takeuchi, K., Hagen, S. J. (2007). Isothiocyanate Inhibits Restitution and Wound Repair after Injury in the Stomach: Ex Vivo and in Vitro Studies. J. Pharmacol. Exp. Ther. 323: 1-9 [Abstract] [Full Text]  
  • Choi, S., Singh, S. V. (2005). Bax and Bak Are Required for Apoptosis Induction by Sulforaphane, a Cruciferous Vegetable-Derived Cancer Chemopreventive Agent. Cancer Res. 65: 2035-2043 [Abstract] [Full Text]  
  • Fahey, J. W., Munoz, A., Matsuzaki, Y., Suzuki, H., Talalay, P., Tauchi, M., Zhang, S., Hurt, C., Yanaka, A. (2004). Dietary Amelioration of Helicobacter pylori Infection: Design Criteria for a Clinical Trial. Cancer Epidemiol. Biomarkers Prev. 13: 1610-1616 [Abstract] [Full Text]  
  • Singh, S. V., Herman-Antosiewicz, A., Singh, A. V., Lew, K. L., Srivastava, S. K., Kamath, R., Brown, K. D., Zhang, L., Baskaran, R. (2004). Sulforaphane-induced G2/M Phase Cell Cycle Arrest Involves Checkpoint Kinase 2-mediated Phosphorylation of Cell Division Cycle 25C. J. Biol. Chem. 279: 25813-25822 [Abstract] [Full Text]